Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

显示更多

首席执行官

Dr. Michael Jeffrey Sinclair

员工

174

国家

英国

ISIN

GB00BD6SX109

WKN

000A2AL9X

上市

STU

R3I1.STU

0 条评论

分享你的想法

常见问题

Advanced Oncotherapy 的股票代码是什么？▼

根据交易所不同，股票代码可能会有所不同。例如，在 Boerse Stuttgart 交易所，Advanced Oncotherapy 的股票以代码 R3I1.STU 进行交易。

Advanced Oncotherapy 有多少名员工？▼

截至2026年11月3日，公司共有174名员工。

Advanced Oncotherapy 属于哪个行业？▼

Advanced Oncotherapy从事于健康与养生行业。

Advanced Oncotherapy 何时完成拆股？▼

Advanced Oncotherapy 最近没有进行任何拆股。

Advanced Oncotherapy 的总部在哪里？▼

Advanced Oncotherapy 的总部位于英国的 London。